Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 1 art units • 1 examiners • 0 of 2 (0%) have an AI response strategy ready
Pandion Operations Inc. has 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These matters are concentrated under 1 distinct examiner and 1 distinct art unit. This level of concentration is notable for the Biotech sector, as it indicates that all of the company's current active filings are being reviewed by the same individual within a single specialized group. This can lead to a very consistent examination experience across the 2 pending office actions.
MERTZ, PREMA MARIA is the busiest examiner for the portfolio, handling 2 pending office actions. This shows that all active prosecution for the company is managed by a single examiner, rather than being distributed across multiple staff members. Because this busiest examiner is responsible for both of the 2 pending office actions, the company's entire current patent strategy at the USPTO is tied to the decisions and timelines of this one individual. This centralized approach simplifies the management of the portfolio.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MERTZ, PREMA MARIA | 2 | 71.7% | +35.4% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18604963 | IL-2 MUTEINS AND USES THEREOF | MERTZ, PREMA MARIA | — |
| 18585285 | IL-2 MUTEINS AND USES THEREOF | MERTZ, PREMA MARIA | — |
| Art Unit | Apps |
|---|---|
| 1646 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18604963 | IL-2 MUTEINS AND USES THEREOF | MERTZ, PREMA MARIA | — | §112DP | Non-Final OA | — | Pending | Mar 14, 2024 |
| 18585285 | IL-2 MUTEINS AND USES THEREOF | MERTZ, PREMA MARIA | 1646 | §112DP | Non-Final OA | — | Pending | Feb 23, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial